Who Paid My Doc
Eric Segal
Neurology with Special Qualifications in Child Neurology N White Plains, NY Medical Doctor
NPI 1770736530 CMS profile 261693
690 N Broadway, Gl1, N White Plains, NY 10603
General payments
$132,705
Research payments
$36,165
Ownership & investment interest
$0
Research they led as principal investigator
$1,567,429
Through program year 2025, Eric Segal of N White Plains, NY is reported in the CMS Open Payments database as having received $132,705 across 703 general payments and $36,165 in research payments paid to them. Separately, studies naming them as principal investigator received $1,567,429 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $18,430 | 101 | |
| 2024 | General | $21,189 | 104 | |
| 2023 | General | $28,442 | 163 | |
| 2022 | General | $19,024 | 116 | |
| 2022 | Research | $36,165 | 7 | |
| 2021 | General | $15,459 | 91 | |
| 2020 | General | $8,831 | 51 | |
| 2019 | General | $21,331 | 77 |
Beside peers
- Eric Segal
- Neurology with Special Qualifications in Child Neurology median
- Middle half of Neurology with Special Qualifications in Child Neurology
- National median
In program year 2025, general payments to Eric Segal were reported at $18,430. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.
Show as a table
| Year | Eric Segal | Neurology with Special Qualifications in Child Neurology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $21,331 | $262 | $68–$1,313 | $163 |
| 2020 | $8,831 | $188 | $46–$1,222 | $114 |
| 2021 | $15,459 | $183 | $45–$1,356 | $132 |
| 2022 | $19,024 | $229 | $72–$1,177 | $149 |
| 2023 | $28,442 | $269 | $93–$1,195 | $160 |
| 2024 | $21,189 | $300 | $98–$1,428 | $164 |
| 2025 | $18,430 | $276 | $87–$1,522 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$13,790
Medicare patients
37
Services billed
84
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 65% | |
| Diabetes | 57% | |
| Heart failure | 54% | |
| Depression | 49% | |
| Arthritis | 49% | |
| Atrial fibrillation | 43% | |
| Chronic kidney disease | 41% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
First 5 of 12 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| VALTOCO |
|
$20,361 | — | — |
| Briviact |
|
$208 | — | — |
| XCOPRI |
|
$120 | — | — |
| Epidiolex |
|
$64 | — | — |
| Motpoly XR |
|
$47 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
See all 12 in the dashboard with a free accountRecords
710 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurology with Special Qualifications in Child Neurology in New York
Claudia Chiriboga
Neurology with Special Qualifications in Child Neurology · New York, NY
Kaleb Yohay
Neurology with Special Qualifications in Child Neurology · New York, NY
Heather Lau
Neurology with Special Qualifications in Child Neurology · New York, NY
Louis Manganas
Neurology with Special Qualifications in Child Neurology · East Setauket, NY
Darryl Devivo
Neurology with Special Qualifications in Child Neurology · New York, NY
Mary Lynn Chu
Neurology with Special Qualifications in Child Neurology · New York, NY
Related records
Neurology with Special Qualifications in Child Neurology in New York
Practitioners in the same specialty and state, ranked by reported value.
All Neurology with Special Qualifications in Child Neurology
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.